Home » News » CROs/Service Providers » Proteomics International, inVentiv Health Clinical ink agreement

Proteomics International, inVentiv Health Clinical ink agreement

Monday, March 3, 2014

Proteomics International, a global accredited proteomics laboratory, has signed a collaborative agreement with inVentiv Health Clinical, a provider of global clinical research and bioanalytical services.

Biosimilar and biologic development begins with extensive structural and functional characterization. Proteomics International provides structural characterization and QC testing of proposed and referenced products with an advanced suite of scientific instrumentation. These services complement inVentiv Health’s array of bioanalytical capabilities from clinical development through commercialization in support of biosimilar development.

The Proteomics International agreement with inVentiv Clinical offers developers the ability to seamlessly transition from characterization to clinical trials, thereby streamlining the process and providing a competitive advantage in the race to market.

Related Posts